Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety of Lapaquistat Acetate in Subjects With Hypercholesterolemia

This study has been completed.
Information provided by (Responsible Party):
Takeda Identifier:
First received: March 18, 2009
Last updated: May 23, 2012
Last verified: May 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2007
  Primary Completion Date: July 2007 (Final data collection date for primary outcome measure)